Gulf Coast TX
NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES
NERLYNX (neratinib) is approved by the Food and Drug Administration of the PhilippinesLeading regional breast cancer oncologists say the availability of NERLYNX is a 'great step fo…
